APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesenchymal Stem Cell Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mesenchymal Stem Cell Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025188 pages

Choose your research edition.

Industry ResearchMesenchymal Stem Cell Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesenchymal Stem Cell Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Mesenchymal Stem Cell Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesenchymal Stem Cell Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesenchymal Stem Cell Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Mesenchymal Stem Cell Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mesenchymal Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mesenchymal Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesenchymal Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mesenchymal Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mesenchymal Stem Cell Drugs include Anterogen, JCR Pharmaceuticals, Medipost, Pharmicell, Stempeutics, Osiris Therapeutics, CHIESI Farmaceutici and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mesenchymal Stem Cell Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesenchymal Stem Cell Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesenchymal Stem Cell Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesenchymal Stem Cell Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesenchymal Stem Cell Drugs Segment by Company

Anterogen

JCR Pharmaceuticals

Medipost

Pharmicell

Stempeutics

Osiris Therapeutics

CHIESI Farmaceutici

Takeda

Mesenchymal Stem Cell Drugs Segment by Type

Autologous Source

Allogeneic Source

Mesenchymal Stem Cell Drugs Segment by Application

Tissue Repair

Immunomodulation

Mesenchymal Stem Cell Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cell Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cell Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cell Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesenchymal Stem Cell Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesenchymal Stem Cell Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mesenchymal Stem Cell Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mesenchymal Stem Cell Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mesenchymal Stem Cell Drugs Industry Trends Table 2. Mesenchymal Stem Cell Drugs Industry Drivers Table 3. Mesenchymal Stem Cell Drugs Industry Opportunities and Challenges Table 4. Mesenchymal Stem Cell Drugs Industry Restraints Table 5. Global Mesenchymal Stem Cell Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mesenchymal Stem Cell Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Mesenchymal Stem Cell Drugs Sales Market Share by Manufacturers Table 9. Global Mesenchymal Stem Cell Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Mesenchymal Stem Cell Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mesenchymal Stem Cell Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mesenchymal Stem Cell Drugs Manufacturers, Product Type & Application Table 13. Global Mesenchymal Stem Cell Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesenchymal Stem Cell Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Autologous Source Table 17. Major Manufacturers of Allogeneic Source Table 18. Global Mesenchymal Stem Cell Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Mesenchymal Stem Cell Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Mesenchymal Stem Cell Drugs Sales Market Share by Type (2021-2026) Table 22. Global Mesenchymal Stem Cell Drugs Sales Market Share by Type (2027-2032) Table 23. Global Mesenchymal Stem Cell Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Mesenchymal Stem Cell Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Mesenchymal Stem Cell Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Tissue Repair Table 29. Major Manufacturers of Immunomodulation Table 30. Global Mesenchymal Stem Cell Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 32. Global Mesenchymal Stem Cell Drugs Sales by Application (2027-2032) & (K Units) Table 33. Global Mesenchymal Stem Cell Drugs Sales Market Share by Application (2021-2026) Table 34. Global Mesenchymal Stem Cell Drugs Sales Market Share by Application (2027-2032) Table 35. Global Mesenchymal Stem Cell Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Mesenchymal Stem Cell Drugs Revenue by Application (2021-2026) & (K Units) Table 37. Global Mesenchymal Stem Cell Drugs Revenue by Application (2027-2032) & (K Units) Table 38. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Application (2021-2026) Table 39. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Application (2027-2032) Table 40. Global Mesenchymal Stem Cell Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Mesenchymal Stem Cell Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Mesenchymal Stem Cell Drugs Sales Market Share by Region (2021-2026) Table 43. Global Mesenchymal Stem Cell Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Mesenchymal Stem Cell Drugs Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 47. North America Mesenchymal Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 48. Europe Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 50. Europe Mesenchymal Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Mesenchymal Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 57. Global Mesenchymal Stem Cell Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Mesenchymal Stem Cell Drugs Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Mesenchymal Stem Cell Drugs Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Region (2021-2026) Table 61. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Region (2027-2032) Table 62. Anterogen Company Information Table 63. Anterogen Business Overview Table 64. Anterogen Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Anterogen Mesenchymal Stem Cell Drugs Product Portfolio Table 66. Anterogen Recent Development Table 67. JCR Pharmaceuticals Company Information Table 68. JCR Pharmaceuticals Business Overview Table 69. JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Product Portfolio Table 71. JCR Pharmaceuticals Recent Development Table 72. Medipost Company Information Table 73. Medipost Business Overview Table 74. Medipost Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Medipost Mesenchymal Stem Cell Drugs Product Portfolio Table 76. Medipost Recent Development Table 77. Pharmicell Company Information Table 78. Pharmicell Business Overview Table 79. Pharmicell Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pharmicell Mesenchymal Stem Cell Drugs Product Portfolio Table 81. Pharmicell Recent Development Table 82. Stempeutics Company Information Table 83. Stempeutics Business Overview Table 84. Stempeutics Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Stempeutics Mesenchymal Stem Cell Drugs Product Portfolio Table 86. Stempeutics Recent Development Table 87. Osiris Therapeutics Company Information Table 88. Osiris Therapeutics Business Overview Table 89. Osiris Therapeutics Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Osiris Therapeutics Mesenchymal Stem Cell Drugs Product Portfolio Table 91. Osiris Therapeutics Recent Development Table 92. CHIESI Farmaceutici Company Information Table 93. CHIESI Farmaceutici Business Overview Table 94. CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Product Portfolio Table 96. CHIESI Farmaceutici Recent Development Table 97. Takeda Company Information Table 98. Takeda Business Overview Table 99. Takeda Mesenchymal Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Takeda Mesenchymal Stem Cell Drugs Product Portfolio Table 101. Takeda Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Mesenchymal Stem Cell Drugs Distributors List Table 105. Mesenchymal Stem Cell Drugs Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Mesenchymal Stem Cell Drugs Product Image Figure 2. Global Mesenchymal Stem Cell Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesenchymal Stem Cell Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesenchymal Stem Cell Drugs Sales (2021-2032) & (K Units) Figure 5. Global Mesenchymal Stem Cell Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mesenchymal Stem Cell Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Autologous Source Image Figure 9. Allogeneic Source Image Figure 10. Global Mesenchymal Stem Cell Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Mesenchymal Stem Cell Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Mesenchymal Stem Cell Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Mesenchymal Stem Cell Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Mesenchymal Stem Cell Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Type (2021-2032) Figure 16. Tissue Repair Image Figure 17. Immunomodulation Image Figure 18. Global Mesenchymal Stem Cell Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Mesenchymal Stem Cell Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Mesenchymal Stem Cell Drugs Sales Market Share by Application (2021-2032) Figure 21. Global Mesenchymal Stem Cell Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Mesenchymal Stem Cell Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 26. U.S. Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 31. Germany Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 38. China Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 46. Brazil Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Mesenchymal Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Mesenchymal Stem Cell Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Mesenchymal Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 57. North America Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Mesenchymal Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 59. Europe Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Mesenchymal Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Mesenchymal Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Mesenchymal Stem Cell Drugs Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Mesenchymal Stem Cell Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Source
  • Allogeneic Source
Applications
  • Tissue Repair
  • Immunomodulation
Companies covered
  • Anterogen
  • JCR Pharmaceuticals
  • Medipost
  • Pharmicell
  • Stempeutics
  • Osiris Therapeutics
  • CHIESI Farmaceutici
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mesenchymal Stem Cell Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mesenchymal Stem Cell Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mesenchymal Stem Cell Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mesenchymal Stem Cell Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mesenchymal Stem Cell Drugs Market Dynamics
  1. 2.1 Mesenchymal Stem Cell Drugs Industry Trends
  2. 2.2 Mesenchymal Stem Cell Drugs Industry Drivers
  3. 2.3 Mesenchymal Stem Cell Drugs Industry Opportunities and Challenges
  4. 2.4 Mesenchymal Stem Cell Drugs Industry Restraints
3 Mesenchymal Stem Cell Drugs Market by Manufacturers
  1. 3.1 Global Mesenchymal Stem Cell Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mesenchymal Stem Cell Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mesenchymal Stem Cell Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mesenchymal Stem Cell Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesenchymal Stem Cell Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mesenchymal Stem Cell Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Mesenchymal Stem Cell Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesenchymal Stem Cell Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesenchymal Stem Cell Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesenchymal Stem Cell Drugs Tier 1, Tier 2, and Tier 3
4 Mesenchymal Stem Cell Drugs Market by Type
  1. 4.1 Mesenchymal Stem Cell Drugs Type Introduction
  2. 4.1.1 Autologous Source
  3. 4.1.2 Allogeneic Source
  4. 4.2 Global Mesenchymal Stem Cell Drugs Sales by Type
  5. 4.2.1 Global Mesenchymal Stem Cell Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mesenchymal Stem Cell Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Mesenchymal Stem Cell Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Mesenchymal Stem Cell Drugs Revenue by Type
  9. 4.3.1 Global Mesenchymal Stem Cell Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mesenchymal Stem Cell Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Mesenchymal Stem Cell Drugs Revenue Market Share by Type (2021-2032)
5 Mesenchymal Stem Cell Drugs Market by Application
  1. 5.1 Mesenchymal Stem Cell Drugs Application Introduction
  2. 5.1.1 Tissue Repair
  3. 5.1.2 Immunomodulation
  4. 5.2 Global Mesenchymal Stem Cell Drugs Sales by Application
  5. 5.2.1 Global Mesenchymal Stem Cell Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mesenchymal Stem Cell Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Mesenchymal Stem Cell Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Mesenchymal Stem Cell Drugs Revenue by Application
  9. 5.3.1 Global Mesenchymal Stem Cell Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mesenchymal Stem Cell Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Mesenchymal Stem Cell Drugs Revenue Market Share by Application (2021-2032)
6 Global Mesenchymal Stem Cell Drugs Sales by Region
  1. 6.1 Global Mesenchymal Stem Cell Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesenchymal Stem Cell Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Mesenchymal Stem Cell Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Mesenchymal Stem Cell Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mesenchymal Stem Cell Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mesenchymal Stem Cell Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mesenchymal Stem Cell Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mesenchymal Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mesenchymal Stem Cell Drugs Revenue by Region
  1. 7.1 Global Mesenchymal Stem Cell Drugs Revenue by Region
  2. 7.1.1 Global Mesenchymal Stem Cell Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mesenchymal Stem Cell Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Mesenchymal Stem Cell Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Mesenchymal Stem Cell Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mesenchymal Stem Cell Drugs Revenue (2021-2032)
  8. 7.2.2 North America Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mesenchymal Stem Cell Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mesenchymal Stem Cell Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mesenchymal Stem Cell Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mesenchymal Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Anterogen
  2. 8.1.1 Anterogen Company Information
  3. 8.1.2 Anterogen Business Overview
  4. 8.1.3 Anterogen Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Anterogen Mesenchymal Stem Cell Drugs Product Portfolio
  6. 8.1.5 Anterogen Recent Developments
  7. 8.2 JCR Pharmaceuticals
  8. 8.2.1 JCR Pharmaceuticals Company Information
  9. 8.2.2 JCR Pharmaceuticals Business Overview
  10. 8.2.3 JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Product Portfolio
  12. 8.2.5 JCR Pharmaceuticals Recent Developments
  13. 8.3 Medipost
  14. 8.3.1 Medipost Company Information
  15. 8.3.2 Medipost Business Overview
  16. 8.3.3 Medipost Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medipost Mesenchymal Stem Cell Drugs Product Portfolio
  18. 8.3.5 Medipost Recent Developments
  19. 8.4 Pharmicell
  20. 8.4.1 Pharmicell Company Information
  21. 8.4.2 Pharmicell Business Overview
  22. 8.4.3 Pharmicell Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmicell Mesenchymal Stem Cell Drugs Product Portfolio
  24. 8.4.5 Pharmicell Recent Developments
  25. 8.5 Stempeutics
  26. 8.5.1 Stempeutics Company Information
  27. 8.5.2 Stempeutics Business Overview
  28. 8.5.3 Stempeutics Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stempeutics Mesenchymal Stem Cell Drugs Product Portfolio
  30. 8.5.5 Stempeutics Recent Developments
  31. 8.6 Osiris Therapeutics
  32. 8.6.1 Osiris Therapeutics Company Information
  33. 8.6.2 Osiris Therapeutics Business Overview
  34. 8.6.3 Osiris Therapeutics Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Osiris Therapeutics Mesenchymal Stem Cell Drugs Product Portfolio
  36. 8.6.5 Osiris Therapeutics Recent Developments
  37. 8.7 CHIESI Farmaceutici
  38. 8.7.1 CHIESI Farmaceutici Company Information
  39. 8.7.2 CHIESI Farmaceutici Business Overview
  40. 8.7.3 CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Product Portfolio
  42. 8.7.5 CHIESI Farmaceutici Recent Developments
  43. 8.8 Takeda
  44. 8.8.1 Takeda Company Information
  45. 8.8.2 Takeda Business Overview
  46. 8.8.3 Takeda Mesenchymal Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takeda Mesenchymal Stem Cell Drugs Product Portfolio
  48. 8.8.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesenchymal Stem Cell Drugs Value Chain Analysis
  2. 9.1.1 Mesenchymal Stem Cell Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesenchymal Stem Cell Drugs Production Mode & Process
  6. 9.2 Mesenchymal Stem Cell Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesenchymal Stem Cell Drugs Distributors
  9. 9.2.3 Mesenchymal Stem Cell Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst